1. Home
  2. TKO vs GH Comparison

TKO vs GH Comparison

Compare TKO & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$184.24

Market Cap

15.1B

Sector

N/A

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$85.88

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKO
GH
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1B
13.3B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
TKO
GH
Price
$184.24
$85.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
19
Target Price
$224.53
$119.79
AVG Volume (30 Days)
1.2M
2.0M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.70%
N/A
EPS Growth
11200.00
6.74
EPS
2.26
N/A
Revenue
$4,735,151,000.00
$982,021,000.00
Revenue This Year
$23.14
$33.30
Revenue Next Year
$1.05
$28.27
P/E Ratio
$81.52
N/A
Revenue Growth
68.85
32.88
52 Week Low
$152.29
$36.36
52 Week High
$226.94
$120.74

Technical Indicators

Market Signals
Indicator
TKO
GH
Relative Strength Index (RSI) 39.29 46.57
Support Level $180.29 $82.33
Resistance Level $192.80 $98.58
Average True Range (ATR) 5.46 4.64
MACD -0.11 -0.12
Stochastic Oscillator 22.61 44.42

Price Performance

Historical Comparison
TKO
GH

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: